At the centre of this shift is Eli Lilly and Company, whose latest investments in China and Japan are helping redefine the next phase of GLP-1 supply strategy
The two-day conference and exhibition features discussions on policy frameworks, AI-led drug discovery, next-generation technologies, and global competitiveness
Biopharma companies face persistent hurdles in cell line development, including long timelines, low yields, and high failure rates for novel molecules
The collaboration promises expanded funding for Thai universities, research institutes, companies, and global research partners working in Thailand
Recognition across subsidiaries and geographies highlights pharma major’s focus on inclusive culture, employee experience, and global workforce development
He brings extensive cross-functional expertise built through leadership roles
Enthral.ai’s platform integrates AI-driven capabilities with compliance-first architecture, enabling automated training workflows
The impact on Phase III trials is particularly significant, as these later-stage studies involve larger, committed patient populations and represent years of investment
As Tracky launches integrated health solution
The Clear Lake facility marks Clariant’s first U.S. site dedicated to PEG excipient production
Subscribe To Our Newsletter & Stay Updated
